Literature DB >> 16285669

Comparative glycoproteomics of N-linked complex-type glycoforms containing sialic acid in human serum.

Ruiqing Qiu1, Fred E Regnier.   

Abstract

This study describes a simple and efficient approach for comparative analysis of sialylated glycoforms of proteins containing differentially branched complex-type glycans. The analytical protocol is based on glycopeptide selection from tryptic digests with serial lectin affinity chromatography (SLAC), quantification with global internal standard technology, fractionation of deglycosylated peptides with reversed-phase chromatography, and peptide sequencing with tandem mass spectrometry. Fractionation of complex tri- and tetraantennary N-linked glycoforms from biantennary N-linked glycoforms bearing terminal sialic acid residues was achieved using a set of serial lectin columns with immobilized Sambucus nigra agglutinin and concanavalin A. These two fractions from the affinity selection were differentially labeled, mixed, and then deglycosylated with the enzyme PNGase F. The deglycosylated sample was further fractionated by reversed-phase chromatography and analyzed by electrospray ionization mass spectrometry. The SLAC strategy was applied to tryptic digests of human serum, and it was found that most sialylated glycopeptides identified carry more biantennary glycans than tri- and tetraantennary glycans, and the relative amount of biantennary glycan versus tri- and tetraantennary glycans was different at separate glycosylation sites within the same glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285669     DOI: 10.1021/ac050554q

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  27 in total

Review 1.  Recent progress in quantitative glycoproteomics.

Authors:  Ying Zhang; Hongrui Yin; Haojie Lu
Journal:  Glycoconj J       Date:  2012-06-15       Impact factor: 2.916

2.  Enhanced N-glycosylation site exploitation of sialoglycopeptides by peptide IPG-IEF assisted TiO2 chromatography.

Authors:  Weiqian Cao; Jing Cao; Jiangming Huang; Lei Zhang; Jun Yao; Haoqi Xu; Pengyuan Yang
Journal:  Glycoconj J       Date:  2012-07-08       Impact factor: 2.916

Review 3.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

4.  Peak capacity optimization of peptide separations in reversed-phase gradient elution chromatography: fixed column format.

Authors:  Xiaoli Wang; Dwight R Stoll; Adam P Schellinger; Peter W Carr
Journal:  Anal Chem       Date:  2006-05-15       Impact factor: 6.986

Review 5.  Comparative glycoproteomics: approaches and applications.

Authors:  Xin Wei; Lingjun Li
Journal:  Brief Funct Genomic Proteomic       Date:  2008-12-17

6.  Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics.

Authors:  Eric D Dodds; Richard R Seipert; Brian H Clowers; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

7.  Automated platform for fractionation of human plasma glycoproteome in clinical proteomics.

Authors:  Majlinda Kullolli; William S Hancock; Marina Hincapie
Journal:  Anal Chem       Date:  2010-01-01       Impact factor: 6.986

8.  Targeting human serum fucome by an integrated liquid-phase multicolumn platform operating in "cascade" to facilitate comparative mass spectrometric analysis of disease-free and breast cancer sera.

Authors:  Subhashini Selvaraju; Ziad El Rassi
Journal:  Proteomics       Date:  2013-04-24       Impact factor: 3.984

Review 9.  Protein biomarkers in cancer: natural glycoprotein microarray approaches.

Authors:  Jia Zhao; Tasneem H Patwa; David M Lubman; Diane M Simeone
Journal:  Curr Opin Mol Ther       Date:  2008-12

10.  Towards an integrated proteomic and glycomic approach to finding cancer biomarkers.

Authors:  Allen D Taylor; William S Hancock; Marina Hincapie; Naoyuki Taniguchi; Samir M Hanash
Journal:  Genome Med       Date:  2009-06-04       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.